CYP3A5 polymorphism, amlodipine and hypertension.

about

Randomized placebo-controlled clinical trial of a chewable formulation of amlodipine for the treatment of hypertension in client-owned cats.Construction and verification of CYP3A5 gene polymorphisms using a Saccharomyces cerevisiae expression system to predict drug metabolism

P2860

Q36974886-4A29277E-6C9A-486C-8E42-B93E256ADF4F Q37720189-BE640059-2C2B-4744-9402-47078791CB69

P2860

CYP3A5 polymorphism, amlodipine and hypertension.

Item

http://www.wikidata.org/entity/Q38122295

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

CYP3A5 polymorphism, amlodipine and hypertension.

@en

type

Item

label

CYP3A5 polymorphism, amlodipine and hypertension.

@en

prefLabel

CYP3A5 polymorphism, amlodipine and hypertension.

@en

P1476

CYP3A5 polymorphism, amlodipine and hypertension.

@en

P2093

H Yuan

http://www.w3.org/2001/XMLSchema#string

J Wen

http://www.w3.org/2001/XMLSchema#string

J-J Cai

http://www.w3.org/2001/XMLSchema#string

X-C Zuo

http://www.w3.org/2001/XMLSchema#string

Y-P Zhang

http://www.w3.org/2001/XMLSchema#string

Z-J Huang

http://www.w3.org/2001/XMLSchema#string

P2860

Prevalence of cardiovascular risk factors in a middle-income country and estimated cost of a treatment strategy.

Genetic contribution to variable human CYP3A-mediated metabolism

Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data

Lessons from rat models of hypertension: from Goldblatt to genetic engineering

Association of CYP3A5 genotypes with blood pressure and renal function in African families

Pharmacogenetics of antihypertensive drug responses

Genetic variability in CYP3A5 and its possible consequences.

CYP3A5 genotype is associated with diagnosis of hypertension in elderly patients: data from the DEBATE Study.

The CoLaus study: a population-based study to investigate the epidemiology and genetic determinants of cardiovascular risk factors and metabolic syndrome.

CYP3A4 and CYP3A5 polymorphisms and blood pressure response to amlodipine among African-American men and women with early hypertensive renal disease

P2888

jhh.2013.67

P304

145-149

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/JHH.2013.67

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Dayue Darrel Duan

P577

2013-07-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1047445300

http://www.w3.org/2001/XMLSchema#string

P698

23863802

http://www.w3.org/2001/XMLSchema#string

CYP3A5 polymorphism, amlodipine and hypertension.

about

P2860

P2860

CYP3A5 polymorphism, amlodipine and hypertension.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698